Cultural differences in acceptability of a vaginal microbicide: A comparison between potential users from nashville, tennessee, usa, and kafue and mumbwa, zambia

HIV/AIDS - Research and Palliative Care

Volumn 4, Issue , 2012, Pages 73-80

  Rice, Valerie Montgomery ^a   Maimbolwa, Margaret C ^b   Nkandu, Esther Munalula ^b   Hampton, Jacqueline Fleming ^c   Lee, Jae Eun ^d   Hildreth, James Ek ^e  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c MEHARRY MEDICAL COLLEGE   (United States)

^d JACKSON STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Birth control; Hiv aids; Sexually transmitted infections; Women

Indexed keywords

MICROBICIDE; UNCLASSIFIED DRUG; VAGINAL MICROBICIDE;

ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE TO HEALTH; COHORT ANALYSIS; CONTROLLED STUDY; CULTURAL FACTOR; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PATIENT ASSESSMENT; PATIENT ATTITUDE; RISK ASSESSMENT; SEXUAL BEHAVIOR; SOUTH AFRICA; UNITED STATES;

EID: 84872952844     PISSN: None     EISSN: 11791373     Source Type: Journal    
DOI: 10.2147/HIV.S25848     Document Type: Article

References (10)

1. McCormack S, Ramjee G, Kamali A, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329-1337.
2. Buckheit RW, Watson KM, Morrow KM, Ham AS. Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res. 2010;85(1):142-158.
3. El-Sadr WM, Mayer KH, Maslankowski L, et al. Safety and accept- ability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS. 2006;20(8):1109-1116.
4. Ramjee G, Morar NS, Braunstein S, Friedland B, Jones H, van de Wijgert J. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa. AIDS Res Ther. 2007;4:20.
5. Whitehead SJ, Kilmarx PH, Blanchard K, et al. Acceptability of Carraguard vaginal gel use among Thai couples. AIDS. 2006;20(17):2141-2148.
6. Central Statistical Offce (CSO), Ministry of Health (MOH), Tropical Disease Research Centre (TDRC), University of Zambia, and Macro International Inc. (2009). Zambia Demographic and Health Survey 2007. Calverton, Maryland, USA: CSO and Macro International Inc. Available from: http://www.measuredhs.com/pubs/pdf/FR211/FR211%5Brevised-05-12-2009%5D.pdf. Accessed February 14, 2012.
7. Karim AQ, Karim SSA, Frohlich JA, et al; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168-1174.
8. van der Straten A, Cheng H, Chidanykia A, De Bruyn G, Padian N. Vaginal practices and associations with barrier methods and gel use among Sub-Saharan African women enrolled in an HIV prevention trial. AIDS Behav. 2010;14(3):590-599.
9. Montgomery CM, Lees S, Stadler J, et al. The role of partnership dynam- ics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733-740.
10. Heiervang E, Goodman R. Advantages and limitations of web-based surveys: evidence from a child mental health survey. Social Psychiatry Psychiatr Epidemiol. 2011;46(1):69-76.